0225/2020 - Acesso a medicamentos de alto preço: Desigualdades na organização e resultados entre estados brasileiros. Access to high price drugs: Inequalities in organization and results among brazilian states.
Este estudo de caso visoucaracterizar a organização do Componente Especializado da Assistência Farmacêutica (CEAF) em 4 estados,de diferentes regiões do país. A coleta de dados foi realizada junto a representantes da gestão do CEAF, os quaisresponderam um questionário com 20 perguntas sobre: abrangência, organização, financiamento, barreiras e facilitadores. Essas informações foram complementadas com dados de inquéritos nacionais de saúde, do DataSUS, os valores investidos (segundo as portarias) e indicadores socioeconômicos.Observaram-se diferenças entre os estadosem questões como a proporção de usuários ea descentralização dosserviços. Estas características parecem estar relacionadas com o grau de desenvolvimento em termos dos indicadores socioeconômicos utilizados. Destacaram-se avanços no acesso a medicamentos, apesar das dificuldades para o cumprimento dos objetivos do CEAF, como a insuficiência de recursos, de qualificação da força de trabalho e da oferta de consultas e exames necessários. Os resultados indicam avanços, diferentes formas de organização e destacam a necessidade de estudos mais aprofundados relativos aos resultados clínicos e econômicos alcançados, como uma estratégia para traçar soluções para o atendimento integral e equânime dos usuários.
Palavras-chave:
Assistência Farmacêutica, Acesso aos Serviços de Saúde, Tecnologia de Alto Custo, Medicamentos Essenciais.
Abstract:
This case studyaimed to characterize the organization of the Specialized Component of Pharmaceutical Services (CEAF) in 4 Brazilian statesdiverse country regions. Data collection was carried out with representatives of CEAF managementstates in different regions of the country, who answered a questionnaire with 21 questions about: scope, organization, financing, barriers and facilitators. This information was complemented with datanational health surveys, DataSUS, the applied resources and socioeconomic indicators. Differences were observed between states on issues such as the proportion of users and the decentralization of services. These characteristics seem to be related to the degree of development in terms of the socioeconomic indicators used. Advances in access to medicines were highlighted, despite the difficulties, such as insufficient resources, the qualification of human resources and the provision of necessary consultations and exams. The results indicate advances, different forms of organization and highlight the need for more in-depth studies on the clinical and economic outcomes, and on the scope of the component as a strategy to achieve the comprehensive and equal care of patients in need of the high-price medicines.
Keywords:
Pharmaceutical Services, Access to Health Services, High-cost Technology, Drugs Essential.
Access to high price drugs: Inequalities in organization and results among brazilian states.
Resumo (abstract):
This case studyaimed to characterize the organization of the Specialized Component of Pharmaceutical Services (CEAF) in 4 Brazilian statesdiverse country regions. Data collection was carried out with representatives of CEAF managementstates in different regions of the country, who answered a questionnaire with 21 questions about: scope, organization, financing, barriers and facilitators. This information was complemented with datanational health surveys, DataSUS, the applied resources and socioeconomic indicators. Differences were observed between states on issues such as the proportion of users and the decentralization of services. These characteristics seem to be related to the degree of development in terms of the socioeconomic indicators used. Advances in access to medicines were highlighted, despite the difficulties, such as insufficient resources, the qualification of human resources and the provision of necessary consultations and exams. The results indicate advances, different forms of organization and highlight the need for more in-depth studies on the clinical and economic outcomes, and on the scope of the component as a strategy to achieve the comprehensive and equal care of patients in need of the high-price medicines.
Palavras-chave (keywords):
Pharmaceutical Services, Access to Health Services, High-cost Technology, Drugs Essential.
Rover, M.R.M, Faraco, E.B, Vargaz-Peláez, C.M, Colussi, C, Storpirits, S., Farias, Mareni R, Leite, S. N.. Acesso a medicamentos de alto preço: Desigualdades na organização e resultados entre estados brasileiros.. Cien Saude Colet [periódico na internet] (2020/jul). [Citado em 22/12/2024].
Está disponível em: http://cienciaesaudecoletiva.com.br/artigos/acesso-a-medicamentos-de-alto-preco-desigualdades-na-organizacao-e-resultados-entre-estados-brasileiros/17707?id=17707&id=17707
